A Prototype Decision-Support Tool for Prioritizing New Vaccines for Development
SMART Vaccines—Strategic Multi-Attribute Ranking Tool for Vaccines—is a pioneering decision-support software tool from the Institute of Medicine being developed to help prioritize new vaccines for development. This software tool has been developed over two phases thus far, resulting in SMART Vaccines Beta (2012) followed by SMART Vaccines 1.0 (2013), as well as two reports: Ranking Vaccines: A Prioritization Framework (2012), and Ranking Vaccines: A Prioritization Software Tool (2013).
SMART Vaccines 1.0
Emerging new infections and re-emerging diseases require new vaccines for prevention. It is difficult to decide which new vaccine to develop, especially when making investment decisions in vaccine development. Thus, decision-makers working under constrained resources need tools that can be suitable within their environment and serve as an aid in vaccine prioritization efforts.
An Introduction To SMART Vaccines
IOM President, Dr. Harvey Fineberg, introduces the new SMART Vaccines 1.0 software prototype.
Windows (XP or above)
Need help? Get in touch with us.
Ranking Vaccines: A Prioritization Framework (2012) describes a multi-attribute utility model to help decision makers with new vaccine prioritization. It also discusses an associated software blueprint called SMART Vaccines Beta and offers ideas for how such a software tool could be employed as a decision support system.
Ranking Vaccines: A Prioritization Software Tool (2013) discusses the methods underlying the development, validation, and evaluation of the significantly redesigned SMART Vaccines 1.0. It describes how SMART Vaccines should--and, just as importantly, should not--be used. The report provides a guiding principle and a set of strategies for future enhancements for SMART Vaccines as well as for ideas for expanded uses and considerations and possibilities for the future.
Included with SMART Vaccines 1.0 are Microsoft Excel files that contain data for the test vaccine candidates. The tables document the calculations and sources used to derive the necessary information. These data table provide the users guidance in ways to gather and estimate data from various sources.
There are two datasets: 1) health burden, and 2) costs associated with the disease. The Phase II report includes a detailed explanation of the methodology used to collect and estimate parameters for the software.